717 filings
Page 5 of 36
8-K
v9wypy8zt7 y1lo
26 Dec 19
Abeona Therapeutics Receives European Medicines Agency PRIME
6:05am
8-K
815gj625hsafi4vx
23 Dec 19
Abeona Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
5:22pm
424B5
drt7q
23 Dec 19
Prospectus supplement for primary offering
5:17pm
25-NSE
0qnz4v7c
20 Dec 19
Exchange delisting
4:34pm
8-K
wszshui2ap
20 Dec 19
Abeona Therapeutics Announces Public Offering of Common Stock and Pre-Funded Warrants
12:00am
424B5
98f1ni
20 Dec 19
Prospectus supplement for primary offering
12:00am
8-K
feijxim1 0mor
10 Dec 19
Company expects to initiate study in the first quarter of 2020
5:11pm
8-K
nbq7ngz1og5a7
12 Nov 19
Abeona Therapeutics Reports Third Quarter 2019 Financial Results and Business Updates
4:38pm
8-K
mb03epz
7 Nov 19
Entry into a Material Definitive Agreement
4:10pm
UPLOAD
8g1cnhc39lo qlu
24 Sep 19
Letter from SEC
12:00am
8-K
pj13x5wrwg cdw
23 Sep 19
Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa
8:50am
CORRESP
q6w6cqegsp2 6jpadk
20 Sep 19
Correspondence with SEC
12:00am
8-K
z7e 7f4o1zg3so70bogk
18 Sep 19
Departure of Directors or Certain Officers
4:15pm
UPLOAD
lmu dc3w2moeeraq3
18 Sep 19
Letter from SEC
12:00am
8-K
wef3l ybgij615
17 Sep 19
Departure of Directors or Certain Officers
10:58am
4
fffoh84u
16 Sep 19
ABEONA THERAPEUTICS / EDWARD CARR ownership change
5:51pm
SC 13G
25p6i6qxgiko454cl5r2
16 Sep 19
Abeona Therapeutics Inc.
4:16pm
SC 13G/A
702upan
10 Sep 19
Abeona Therapeutics Inc.
11:19am
8-K
ofwvxldrp
4 Sep 19
Abeona Therapeutics Announces Strategic Review
4:07pm